Pay in 4 interest-free payments of $7.13 Learn more
Ships within 48 hours · Estimated delivery Sep 6 - Sep 11
New treatment options bring hope to the many people with obesity who struggle with this disease and are seeking better options for weight management. The approval was based on results from the phase III SURMOUNT-1 and SURMOUNT-2 trials
Selective FLT3 inhibitor FI-700 neutralizes Mcl-1 and enhances p53-mediated apoptosis in AML cells with activating mutations of FLT3 through Mcl-1/Noxa axis
Oral supplements might serve as maintenance between injection cycles
Unfortunately, many patients regain weight after discontinuation, so these medications are currently seen as a long-term therapy
US$ 20.74
US$ 24.76
US$ 27.85
US$ 21.17
US$ 23.50
